SG Americas Securities
ABCL icon

SG Americas Securities’s AbCellera Biologics ABCL Stock Holding History

SG Americas Securities’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70K Buy
+20,200
New +$72.7K ﹤0.01% 2989
2025
Q3 		– Sell
-21,979
Closed -$75K – 3349
2025
Q2 		$75K Buy
21,979
+6,402
+41% +$15.9K ﹤0.01% 2695
2025
Q1 		$35K Buy
+15,577
New +$44.7K ﹤0.01% 3310
2023
Q2 		– Sell
-36,208
Closed -$273K – 2213
2023
Q1 		$273K Buy
+36,208
New +$329K ﹤0.01% 2190
2022
Q4 		– Sell
-160,643
Closed -$1.59M – 3032
2022
Q3 		$1.59M Buy
160,643
+150,966
+1,560% +$1.66M 0.02% 709
2022
Q2 		$103K Buy
+9,677
New +$81.9K ﹤0.01% 3107

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return